SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-18-000190
Filing Date
2018-10-24
Accepted
2018-10-24 16:02:16
Documents
40
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT-SEPT. 30, 2018 bfnh10182018form10qsept.htm 10-Q 125306
2 CERTIFICATION ex311.htm EX-31.1 5013
3 CERTIFCATION ex312.htm EX-31.2 5009
4 CERTIFICATION ex321.htm EX-32.1 2073
5 CERTIFICATION ex322.htm EX-32.2 2018
12 bfnhlogo001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-18-000190.txt   877478

Data Files

Seq Description Document Type Size
6 bfnh-20180930.xml EX-101.INS 70205
7 bfnh-20180930.xsd EX-101.SCH 13399
8 bfnh-20180930_cal.xml EX-101.CAL 24430
9 bfnh-20180930_def.xml EX-101.DEF 16916
10 bfnh-20180930_lab.xml EX-101.LAB 90341
11 bfnh-20180930_pre.xml EX-101.PRE 70406
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

IRS No.: 743078125 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 181136425
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences